J Gen Virol Try Microbiology Online
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 89 (2008), 653-659; DOI 10.1099/vir.0.83386-0

IMMEDIATE OPEN ACCESS ARTICLE
This Article
Free via Open Access: OA
Right arrow OA Free Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Owsianka, A. M.
Right arrow Articles by Patel, A. H.
PubMed
Right arrow Articles by Owsianka, A. M.
Right arrow Articles by Patel, A. H.
Agricola
Right arrow Articles by Owsianka, A. M.
Right arrow Articles by Patel, A. H.

Short Communication

Broadly neutralizing human monoclonal antibodies to the hepatitis C virus E2 glycoprotein

Ania M. Owsianka1,{dagger}, Alexander W. Tarr2,{dagger}, Zhen-Yong Keck3, Ta-Kai Li3, Jeroen Witteveldt1, Richard Adair1, Steven K. H. Foung3, Jonathan K. Ball2 and Arvind H. Patel1

1 MRC Virology Unit, Institute of Virology, University of Glasgow, Church Street, Glasgow G11 5JR, UK
2 The Institute of Infection, Immunity and Inflammation, School of Molecular Medical Sciences, The University of Nottingham, Queen's Medical Centre, Nottingham NG7 2UH, UK
3 Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA

Correspondence
Arvind H. Patel
a.patel{at}mrcvu.gla.ac.uk

The humoral response to hepatitis C virus (HCV) may contribute to controlling infection. We previously isolated human monoclonal antibodies to conformational epitopes on the HCV E2 glycoprotein. Here, we report on their ability to inhibit infection by retroviral pseudoparticles incorporating a panel of full-length E1E2 clones representing the full spectrum of genotypes 1–6. We identified one antibody, CBH-5, that was capable of neutralizing every genotype tested. It also potently inhibited chimeric cell culture-infectious HCV, which had genotype 2b envelope proteins in a genotype 2a (JFH-1) background. Analysis using a panel of alanine-substitution mutants of HCV E2 revealed that the epitope of CBH-5 includes amino acid residues that are required for binding of E2 to CD81, a cellular receptor essential for virus entry. This suggests that CBH-5 inhibits HCV infection by competing directly with CD81 for a binding site on E2.

{dagger}These authors contributed equally to this work.




This article has been cited by other articles:


Home page
J. Virol.Home page
Z.-Y. Keck, O. Olson, M. Gal-Tanamy, J. Xia, A. H. Patel, M. Dreux, F.-L. Cosset, S. M. Lemon, and S. K. H. Foung
A Point Mutation Leading to Hepatitis C Virus Escape from Neutralization by a Monoclonal Antibody to a Conserved Conformational Epitope
J. Virol., June 15, 2008; 82(12): 6067 - 6072.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
Z.-Y. Keck, T.-K. Li, J. Xia, M. Gal-Tanamy, O. Olson, S. H. Li, A. H. Patel, J. K. Ball, S. M. Lemon, and S. K. H. Foung
Definition of a Conserved Immunodominant Domain on Hepatitis C Virus E2 Glycoprotein by Neutralizing Human Monoclonal Antibodies
J. Virol., June 15, 2008; 82(12): 6061 - 6066.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 2008 by the Society for General Microbiology.